Moderna Inc - Company Profile
Powered by
All the data and insights you need on Moderna Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Moderna Inc Strategy Report
- Understand Moderna Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View moreView up-to-date information on Moderna Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP3852814A4 | Search Report | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR FREISETZUNG VON NUKLEINSÄUREN | A61K31/7088; C12N15/111; C12N15/67; C12N15/88; C12N2310/11; C12N2310/152; C12N2310/3519; C12N2310/51; C12N2310/531; C12N2320/31 | September 14, 2022 |
WO2022187698A1 | Application | VLP ENTEROVIRAL VACCINES | Y02A50/30 | September 09, 2022 |
AU2016342048B2 | Grant | Broad spectrum influenza virus vaccine | A61K2039/5252; A61K2039/5254; A61K2039/53; A61K2039/54; A61K2039/545; A61K2039/6018; A61K2039/70; A61K31/7105; A61K39/12; A61K39/145; A61P31/14; A61P31/16; A61P37/04; A61P43/00; C12N2760/16134 | September 08, 2022 |
US20220280639A1 | Application | COMPOSITIONS AND METHODS FOR DELIVERY OF RNA INTERFERENCE AGENTS TO IMMUNE CELLS | A61K2039/53; A61K39/39; A61K47/14; A61K47/24; A61K9/0019; A61K9/1272 | September 08, 2022 |
US11434486B2 | Grant | Polynucleotides containing a morpholino linker | C12N15/111; C12N15/113; C12N2310/317; C12N2310/321; C12N2310/3231; C12N2310/3233; C12N2310/351; C12N2320/51 | September 06, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer